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ABSTRACT   
Cellulose nanofibrils (CNFs) from wood pulp are a renewable material possessing 
advantages for biomedical applications, due to their customizable porosity, mechanical 
strength, translucency and environmental biodegradability.  Here we investigated the 
growth of multi-species wound biofilms on CNF formulated as aerogels and films 
incorporating the low molecular weight alginate oligosaccharide OligoG CF-5/20 to 
evaluate their structural and antimicrobial properties.  Overnight microbial cultures 
were adjusted to 2.8 x 109 colony forming units (cfu) mL-1 in Mueller Hinton broth and 
growth rates of P. aeruginosa PAO1 and S. aureus 1061A monitored for 24 h in CNF 
dispersions sterilized by -irradiation.  Two CNF formulations were prepared (20 g m-
2) with CNF as air-dried films or freeze-dried aerogels, with or without incorporation 
of an antimicrobial alginate oligosaccharide (OligoG CF-5/20) as a surface coating or 
bionanocomposite respectively. The materials were structurally characterized by 
scanning electron microscopy (SEM) and laser profilometry (LP).  The antimicrobial 
properties of the formulations were assessed using single- and mixed-species biofilms 
grown on the materials and analysed using LIVE/DEAD® staining with confocal laser 
scanning microscopy (CLSM) and COMSTAT software.  OligoG-CNF suspensions 
significantly decreased the growth of both bacterial strains at OligoG concentrations 
>2.58% (P<0.05).  SEM showed that aerogel-OligoG bionanocomposite formulations 
had a more open 3-dimensional structure, while LP showed film formulations coated 
with OligoG were significantly smoother than untreated films or films incorporating 
PEG400 as a plasticizer (P<0.05).  CLSM of biofilms grown on films incorporating 
OligoG demonstrated altered biofilm architecture, with reduced biomass and decreased 
cell-viability.  The OligoG-CNF formulations as aerogels or films both inhibited 
pyocyanin production (P<0.05).  These novel CNF formulations or bio-nanocomposites 
were able to modify bacterial growth, biofilm development and virulence factor 
production in vitro.  These data support the potential of OligoG and CNF bio-
nanocomposites for use in biomedical applications where prevention of infection or 
biofilm growth is required. 
  
 
 
INTRODUCTION 
In the last 10 years, nanocellulose research has expanded exponentially.  Nanocellulose 
includes cellulose nanofibrils (CNFs), cellulose nanocrystals (CNCs) and bacterial 
cellulose (BC).  As a potentially inexhaustible natural polymer from sustainable 
sources, its bio-sustainability is a major driving force behind this increased interest.1  
Nanocelluloses possess a myriad of useful material properties such as biodegradability 
in nature, mechanical strength, modifiable surface chemistry and biocompatibility 
which may be applied in a wide range of industrial and clinical applications.2  One of 
these applications is in the design of wound dressing materials.  
Chronic, non-healing skin wounds are an important, often recognized source of 
morbidity,3 which is increasing in incidence annually, with the ageing population and 
the inexorable rise of obesity and diabetes.  In health, the skin is colonized by a diverse 
“reservoir” of pathogenic and beneficial bacteria, which do not abnormally affect the 
host.  In disease however, pathogens from the normal skin microbiota can become a 
serious problem in terms of infection, morbidity and quality of life.  Infections in 
chronic wounds have been found to be associated with the presence of bacterial biofilms 
in up to 75% of cases.4  Bacteria in these biofilms are encased in a charged “polymeric 
mesh” of host- and bacteria-derived extracellular polymers which resist physical and 
chemical (antimicrobial) disruption and have increased resistance to antimicrobial and 
antibiotic therapy due to both the physical barrier, and also alterations of bacterial 
metabolism within the biofilm matrix.5  Chronic wounds are polymicrobial, the most 
common isolates being the commensals, Pseudomonas aeruginosa and Staphylococcus 
aureus.6  Whilst the aetiology of non-healing wounds is undoubtedly multi-factorial, 
bacteria play a significant role in perpetuating the inflammation and proteolytic wound 
environment.  Indeed, studies have demonstrated impaired wound healing associated 
with bacterial and fungal colonization.7,8  
In the current treatment of chronic wounds a wide array of wound dressings are 
employed varying in their physical composition (films, foams, hydrogels, 
hydrocolloids) and biological activity (dermis, cell-based products and anti-bacterial 
compounds) and are made from an increasing number of materials such as 
polyurethane, carboxymethylcellulose and natural polymers e.g. collagen, alginates, 
starches, and hyaluronic acid.9  
The potential to “customize” nanocellulose dressing materials with different 
mechanical and physical properties for distinct indications in wound dressing materials 
 
 
now exists. Indeed, we recently described the use of CNFs from wood pulp as a 
prototype wound dressing material.10,11  Nanofibrils are produced mechanically from 
cellulose fibers by the use of high-pressure homogenisation and/or grinding which de-
laminates the fibers, releasing the nanofibrils.  The longer the homogenisation steps, 
the more nanofibrils are liberated.12  The use of chemical pre-treatments, such as 
TEMPO-mediated oxidation,13 may not only selectively introduce carboxylate groups 
onto the surface of the CNFs,14 but also radically reduce the energy costs for the 
mechanical processing; making the homogenisation steps more cost-effective.15  Hence, 
a combination of chemical and mechanical treatments are often used.  Above a critical 
concentration, TEMPO nanofibrils display gel-like properties in water16 and have a 
high aspect ratio, lengths in the micrometre-scale and widths of ~4 nm.17  
The abundance of CNFs from renewable sources, its relatively low cost, its natural 
biodegradability and its excellent mechanical properties are all distinct advantages for 
its exploitation as a wound dressing material.  Moreover, its ability to “self-assemble” 
into 3-dimensional micro-porous structures confers a high capacity for absorbance; a 
useful property in wounds with high levels of wound exudate.18  The ability to now 
produce wood CNF that is ultrapure (low endotoxin), with low cytotoxicity levels, also 
reinforces its potential as a material for biomedical applications, such as “scaffolds” in 
wound dressings.19  Manipulation and tailoring of the CNF hydrophilic surface 
chemistry can be used to functionalize the materials to make them pH responsive or to 
allow incorporation of antimicrobial agents.  We previously demonstrated that the 
physical form of CNF-derived materials may vary dependent upon their formulation; 
being antimicrobial in suspension as hydrogels (against P. aeruginosa) but not when 
prepared as films or aerogels.11  We have also established how porosity and surface 
roughness may influence bacterial growth on the CNF aerogels, with less biofilm 
growth being associated with lower porosity and roughness.  For wound dressing 
materials, the design of CNF materials with intrinsic antibacterial ability would clearly 
be useful. 
OligoG is a natural product derived from alginate extracted from the stem of the 
brown seaweed Laminaria hyperborea, and possesses antibacterial20-25 and antifungal 
properties.26,27  Unlike antibiotics and silver, prolonged exposure to OligoG does not 
lead to the acquisition of resistance.20  These antimicrobial properties, combined with 
the excellent safety profile, make alginate oligosaccharides potentially useful for 
incorporation into dressing materials for use in wound healing.   
 
 
To further investigate the potential clinical application of CNF dressing materials 
in chronic human skin wound healing, we examined single and mixed species biofilms 
grown on CNF prepared as two different structural formulations (aerogels and films) 
with or without incorporation of the antimicrobial OligoG.   
 
 
MATERIALS AND METHODS 
 
CNF Production.  Pinus radiata bleached kraft pulp fibers were used as the raw 
material for CNF production.  The pulp fibers were pretreated with TEMPO-mediated 
oxidation28 using 3.8 mM hypochlorite (NaOCl) g-1 cellulose.  The pre-treated fibers 
were then extensively washed with deionized water until the conductivity was below 5 
µS/cm. The CNF were produced through homogenization using a Rannie 15 type 
12.56X homogenizer.  The material (1% solids content) was homogenized with a 
pressure drop of 1000 pascal units and collected after 2 or 3 passes through the 
homogenizer.  
Sample Preparation.  CNF samples (Table 1) were produced by solution casting 
in sterile petri dishes, followed by either air-drying to produce low porosity films or 
freeze-drying to yield more porous aerogel structures.  PEG400 was incorporated into 
the films for increased plasticity29 with 40% PEG shown to be sufficient to improve the 
ductility of the films, whilst having adequate liquid absorption and without affecting 
its’ cytocompatibility.  In addition, the antimicrobial OligoG derived from marine 
algae20 was either incorporated into the CNF aerogels to produce a bionanocomposite 
or surface-coated onto the CNF films.   
CNF materials (for the dried films and aerogels) were used as 0.2% suspensions 
(grammage 20 g m-2) throughout.  Bionanocomposite films were made using 0.2% 
(w/v) twice homogenised CNF dispersions ±PEG400 (40%, w/v) which were air-dried 
at room temperature (~20°C) for 5-7 days.  Surface coating with OligoG was performed 
on air-dried films using a 0.2% (w/v) OligoG solution, by pouring this evenly onto the 
film surface within the petri-dish and allowing it to air-dry at 37°C for 48 h to a final 
concentration of 0.9 mg cm-2 film (as determined by weight of material before and after 
coating).  Freeze-dried aerogels were prepared using 0.2% (w/v) thrice homogenised 
CNF dispersions ± OligoG (to give a final concentration of 2%), before being frozen in 
petri dishes at -20ºC and freeze-dried for 48 h.   
 
 
All the samples were cut into 1 or 2 cm2 sections and sterilized by γ-irradiation (15 
kGy).  Commercially-available wound dressings AquaCel® and AquaCel Ag® 
(ConvaTec Ltd, Deeside) were used as controls. 
 
Table 1.  Characteristics and Absorbency (n=3) of the CNF Materials Used.  
CNF 
material 
Sample name No. of 
homogenisation 
steps used10,11 
OligoG 
concentration 
(%) 
PEG400 
(%) 
Fluid 
Absorption 
(g/g) 
Aerogel A0.2 3 0 0 111.65 
Aerogel A0.2G 3 2‡ 0 11.31 
Film F0.2 2 0 0 5.83 
Film F0.2G 2 0.2§ 0 8.11 
Film F0.2P† 2 0 40‡ 6.70 
Control AquaCel®    25.4611 
Control AquaCel Ag®    26.2811 
†PEG400 incorporated into the film to enhance plasticity.   
‡Bio-nanocomposite, with 2% OligoG CF-5/20 incorporated into the aerogels.   
§OligoG CF-5/20 (0.2%) surface coating of films to a final concentration of 0.9 mg 
cm-2.   
 
 
 
Absorption Measurements.  Fluid absorption of the test and control materials was 
assessed as previously described.11  
Screening for the Ability of CNF to Support Bacterial Growth.  Jack et al. 
(2017) originally examined the growth of P. aeruginosa in CNF hydrogels.  For this 
study, the ability of the same CNF dispersions (homogenised three times) to inhibit or 
promote growth of another wound bacterium, S. aureus, in planktonic culture was also 
examined.  CNF dispersions were prepared at 0.2, 0.4 or 0.6% (w/v) and sterilized by 
γ-irradiation.   
For the growth curves, overnight bacterial cultures of P. aeruginosa PAO1 and S. 
aureus 1061A (both wound isolates) were diluted to 2.8 x 109 cfu mL-1 in either 
Mueller-Hinton (MH) broth, PBS or deionized water, and mixed 1:2 (v/v) with 0.2% 
(w/v) CNF dispersions or water in a 24 well plate.  Plates were incubated at 37⁰C 
 
 
aerobically for 24 h measuring optical density every hour at 600 nm (OD600) in a 
FLUOstar Optima plate reader (BMG LABTECH).   
Log10 reduction assay.  Time-kill assays were used to evaluate the antimicrobial 
efficacy of the aerogel and film materials against S. aureus 1061A in comparison to a 
commercially available wound dressing containing silver AquaCel (Ag)® as previously 
described (Jack et al 2017).  
The effect of PEG400 and/or OligoG with CNF dispersions on bacterial 
growth.  The effect of CNF dispersions with/without PEG 400 and/or OligoG on the 
growth of either P. aeruginosa PAO1 or S. aureus 1061A was determined using growth 
curves.  CNF dispersions were diluted in deionized sterilized water to final 
concentrations of 0.2% ±OligoG CF-5/20 (0.2, 2 or 2.58%) and/or ±PEG400 (40%).  
Growth curves were carried out as described above. 
Scanning Electron Microscopy (SEM).  CNF aerogel samples (A0.2 and A0.2G) 
were prepared for SEM analyses by immersion in glutaraldehyde (2.5%) for 24 h, 
before being washed with deionised water (x4) and immersed in fresh deionised water.  
The samples were then frozen (24 h) and freeze-dried for 24 h.  The material surface 
was then imaged on the Tescan Vega SEM at 5 kV.   
Biofilm growth on CNF formulations.  Samples (1 cm2) of formulations A0.2 
and A0.2G (aerogels) and F0.2, F0.2G and F0.2P (films) were added to a 12-well plate 
containing MH broth (3 mL) and 60 µL of P. aeruginosa PAO1 and/or S. aureus 1061A 
overnight cultures (adjusted to 6.1 x 109 cfu mL-1).  Plates were incubated at 37ºC in a 
static aerobic environment for 24 h before removing the supernatant and then washing 
the biofilms once with PBS.   
Confocal Laser Scanning Microscopy (CLSM) imaging of Biofilm Growth on 
CNF Materials.  Biofilms were stained with LIVE/DEAD® BacLight™ bacterial 
viability kit (Invitrogen, Paisley, UK) containing SYTO 9 dye (staining LIVE cells, 
green) and propidium iodide (staining DEAD cells, red) and incubated in the dark (10 
min). The samples were then mounted onto microscope slides with spacers with the 
addition of Vectorshield (Vector Laboratories, UK), before being covered with a 
coverslip and sealed with clear nail-varnish.  Biofilms were imaged with a Leica TCS 
SP5 confocal system using a x63 lens.  Bacterial growth was quantified using 
COMSTAT image-analysis software.30 
Effect of CNFs on Pyocyanin Production.  Overnight cultures of P. aeruginosa 
PAO1 were adjusted to 6 x 1011 cfu mL-1, and 60 µL added to MH-broth (6 mL) in a 6-
 
 
well plate and grown statically for 24 h ± CNF formulations (A0.2, A0.2G, F0.2, F0.2G 
and F0.2P) or AquaCel (Ag)® (2 x 2 cm2).  Bacterial cultures were then centrifuged 
(10000 g) for 10 min to produce a cell-free culture supernatant and used for the 
extraction of virulence factors.  
Pyocyanin pigment was extracted from the cell-free supernatant using chloroform 
(3:2; v/v).  Pyocyanin (in the chloroform-phase) was re-extracted with 0.2 M HCl (2:1; 
v/v) and the absorbance read at 540 nm.31 
Laser Profilometry.  To directly study the surface of the CNF materials, samples 
(10 mm x 10 mm) were cut from the dried film materials (F0.2, F0.2G and F0.2P) for 
surface analysis (and surface roughness measurements) using laser profilometry (LP) 
as previously described.32  LP could not be performed on the aerogels due to the 
limitations of the laser beam/detector system in detecting the steep surface gradients 
associated with these materials.   
Ion Milling.  To directly study biofilm growth on the CNF materials, cross-
sections of the A0.2 and A0.2G aerogels with P. aeruginosa PAO1 biofilm growth, 
(prepared as for SEM), were made by ion-milling using an IM4000 system and a milling 
time of 5 h at 2.5 kV.  Images of the samples were then acquired using a Hitachi 
scanning electron microscope (SU3500) in secondary electron imaging, low-vacuum 
mode, using 3-5 kV acceleration voltage. 
Statistical Analysis.  SPSS (IBM Corp, New York, USA) or GraphPad Prism 3 
(GraphPad software Inc, La Jolla, USA) were used to perform statistical analysis.  The 
following tests were used including: minimum significant difference (MSD) calculated 
using the Tukey-Kramer method (growth curve data), ANOVAs of log or log(2-X) 
transformed data (to correct for normality) using Kw, Tukey-Kramer or Dunn’s 
Multiple Comparisons Tests (COMSTAT and laser profilometry data) and Student’s T-
test (pyocyanin data).  P<0.05 was considered significant. 
 
 
RESULTS 
Bacterial growth in CNF dispersions.  As we have previously shown with P. 
aeruginosa,11 S. aureus was unable to use CNF as a carbon source.  CNF incubated 
with MH broth (Supporting Information, Figure S1A) showed good growth, but this 
was not seen in CNF incubated with water or PBS (Supporting Information, Figure 
S1B and C), suggesting any observed growth was solely due to the MH broth and not 
 
 
the CNF.  In addition, a slight inhibitory effect of the CNF hydrogel was observed 
compared to the MH control (Supporting Information, Figure S1A).  This inhibitory 
effect was not seen in the Log10 reduction assay with the dried aerogel or film materials 
(Supporting Information, Figure S1D). 
Growth curves for the wound microorganisms S. aureus (1061A) and P. 
aeruginosa PAO1 were performed with CNF dispersions with/without OligoG CF-5/20 
and PEG400 (Figure 1).  When grown with OligoG alone, a significant decrease in 
growth of both S. aureus (Figure 1A; MSD=0.1756) and P. aeruginosa PAO1 (Figure 
1B; MSD=0.2489) was observed at 10%.  PEG400 (40%) alone (without MH broth) 
did not appear to support the growth of either microorganism (Figures 1C and 1D; 
MSD=0.2241 and 0.1168 respectively).  In contrast, low levels of bacterial growth were 
evident in PEG400 with the addition of MH, with similar growth levels also seen for 
the PEG400 + OligoG CF-5/20 growth curves, (at every concentration of OligoG 
tested) with only P. aeruginosa at 2.58% OligoG demonstrating any apparent, but 
slight, inhibition of growth.   
Scanning Electron Microscopy of CNF formulations.  Surface 
characterisation of the aerogels (A0.2 and A0.2G) using SEM demonstrated distinct 
differences between the two materials.  The A0.2 formulation had an undulating 
surface, which appeared to be much denser than the CNF-OligoG bionanocomposite 
(A0.2G), which had a much rougher, more open network of fibres with fissures 
penetrating into the 3-dimensional structure (Figure 2A). 
Laser profilometry of CNF film formulations.  Laser profilometry of the 
films F0.2, F0.2G and F0.2P, (Figures 2B and C) showed distinct differences in the 
material surfaces, especially for the OligoG-surface coated formulation (F0.2G) and the 
bionanocomposite film incorporating PEG400 (F0.2P) which both exhibited 
significantly decreased surface-roughness (P<0.05).  The OligoG coated film (F0.2G) 
was also much smoother than the bionanocomposite containing PEG (F0.2P). 
 
 
 
 
 
Figure 1. Effect of PEG400 (40%, w/v) and/or OligoG CF-5/20 (0.2, 2 or 2.58%) on bacterial growth in T3 CNF (0.2%) in MH broth 
(unless otherwise stated) of (a, c) S. aureus 1061A. (b, d) P. aeruginosa (PAO1).  MSD, minimum significant difference (n=3; P<0.05).  
 
 
 
 
 
 
 
 
 
Confocal laser scanning microscopy of P. aeruginosa and S. aureus single 
and mixed species biofilms grown on CNF formulations.  CLSM of biofilms grown 
on the films and then stained with LIVE/DEAD® cell viability dyes showed that the 
untreated (control) films (F0.2) produced the thickest biofilms, as well as complete 
surface coverage with bacteria (Figure 3A).  for films coated with OligoG (F0.2G; 
Figure 3B), a markedly reduced bacterial biofilm biomass was evident, with 
significantly decreased biomass observed by Comstat analysis in both the P. 
aeruginosa and the mixed species biofilms (p<0.05; Figure 3D) which was associated 
with increased bacterial “clumping”, i.e. aggregation, compared to that observed in the 
control (F0.2).  However, this effect was not evident in films incorporating PEG400 
(F0.2P; Figure 3C).  In addition, significant decreases in mean thickness and 
significant increases in surface roughness (Figure S2) in single species P. aeruginosa 
and S. aureus biofilms were evident after growth on OligoG coated surfaces (p<0.05).  
In contrast, although mixed species biofilms grown on the CNF films with PEG400 
exhibited an increased loss of cell viability when compared to P. aeruginosa and S. 
aureus only biofilms (Figure 3C), this was not shown to be significant in the Comstat 
analysis (Figures 3D and S2A,B).     
Figure 2. Structural characterization of CNF formulations. Scanning electron 
microscopy (SEM) of (a) aerogels A0.2 and A0.2G. (b) Laser profilometry (LP) of 
films F0.2, F0.2G and F0.2P.  (c) Corresponding surface roughness measurements 
(from LP only). (*significantly different compared to the F0.2 control; n=3; P<0.05).  
 
 
Figure 3. CLSM images of LIVE/DEAD
®
 staining of 24 h single and dual species biofilms grown on CNF films. (a) Control F0.2. (b) 
OligoG-coated F0.2G. (c) PEG400 biocomposite F0.2P.   COMSTAT image analysis showing (d) mean biofilm biomass of LIVE (green) 
and DEAD (red) cells.  (*significantly different compared to the equivalent no OligoG control; n=10 images each from n=3 replicates; 
P<0.05).  
 
 
  
Figure 4. CLSM images of LIVE/DEAD
®
 staining of 24 h single and dual species biofilms grown on CNF aerogels. (a) Control A0.2. (b) 
Oligo-bio-nanocomposite A0.2G.  COMSTAT image analysis showing mean biofilm of LIVE (green) and DEAD (red) cells:  (c) Biomass.  
(d) Thickness. (*significantly different compared to the equivalent no OligoG control; n=10 images each from n=3 replicates; P<0.05).    
 
 
CLSM studies on the aerogel formulations revealed that untreated aerogels 
supported considerable biofilm biomass on the material surface (Figure 4A).  Although 
a small number of dead cells were apparent in these images, non-vital bacterial cells 
within P. aeruginosa and mixed species biofilms increased on aerogels incorporating 
2% OligoG (A0.2G; Figure 4B,C) however, this was not evident in the S. aureus 
biofilms.  Whilst the OligoG aerogels (A0.2G) appeared to exhibit decreased bacterial 
biofilm biomass (Figure 4C) and thickness (Figure 4D), when compared to the 
untreated material (A0.2), these effects did not reach statistical significance (Figure 
4C,D and S2; P>0.05).  This lack of significance in the aerogel assays could be due to 
the inherent surface roughness of these materials, producing irregular biofilm 
structures, making them difficult to quantify. 
Effect of the different CNF materials on production of the virulence factor 
pyocyanin by P. aeruginosa PAO1.  The untreated CNF materials (A0.2 and F0.2) 
had no apparent effect on production of pyocyanin by PAO1 (Figure 5).  However, 
incorporation of OligoG in both formulations (F0.2G, A0.2G) or PEG in the films 
(F0.2P) inhibited pyocyanin production (P<0.05).  This inhibition was statistically 
significant in the F0.2P and A0.2G formulations.   
 
 
 
 
 
Figure 5. The effect of the different CNF formulations on pyocyanin production by 
P. aeruginosa PAO1. PAO1 and MH broth only were positive and negative controls 
respectively.  (*significantly different compared to the PAO1 control; n=3; P<0.05).    
 
 
 
SEM imaging of P. aeruginosa and S. aureus mixed species biofilms on CNF 
aerogels.  Ion-milling of the aerogels (A0.2 and A0.2G) showed distinct differences 
between the 3-dimensional structure of the materials, with the CNF-OligoG 
bionanocomposite A0.2G displaying more numerous, tightly packed ruffles 
(stratification) in cross-section than the untreated aerogel A0.2 (Figure 6A).  Biofilms 
were also clearly visible growing on the surface of the untreated formulation (A0.2), 
compared to the aerogel containing the antimicrobial alginate OligoG (A0.2G; Figure 
6B). 
 
 
 
 
 
 
 
DISCUSSION 
Nanocellulose is increasingly being used for medical applications such as wound 
dressing materials, and as tissue engineering scaffolds to support host cell attachment 
and cell delivery.33-35  Mechanically delaminated cellulose nanofibrils are attractive for 
biomedical applications due to their physical properties and biocompatibility.36-38  
Figure 6. Scanning electron microscopy (SEM) imaging of a P. aeruginosa and S. 
aureus mixed species biofilm growing on untreated aerogels A0.2 or the OligoG bio-
nanocomposite A0.2G. (a) Cross-sectional view following ion milling. (b) Aerial 
view with inset magnified areas showing biofilm growth.  
 
 
Importantly, alongside their sustainability, the recent ability to employ 
environmentally-friendly, non-toxic chemical processes, such as freeze-drying of 
aerogels as opposed to solvent exchange,39 to produce CNF materials is 
environmentally attractive.  Moreover, the surface chemistry of CNF materials can also 
be tailored (for example, by altering the choice of crosslinking ions such as calcium or 
copper) to have very different antimicrobial properties.40  In the design of future CNF-
based wound dressing materials, the incorporation of antimicrobials might clearly 
afford clinical benefit.   
The incorporation of antimicrobials (e.g. silver or iodine) into wound dressing 
materials for sustained release has already been utilised in clinical settings.  A recent 
study demonstrated that antibacterial agents can be readily released from freeze-dried 
CNF materials on conversion into a hydrogel in an aqueous environment,41 highlighting 
the ability of stored dried aerogels to be ‘activated’ by hydration and still retain their 
antimicrobial properties, as might occur on exposure to an exudating wound. 
Importantly, we have previously reported the morphology and carboxyl content of CNF 
dressing materials obtained from the same P. radiata pulp fibers. The nanofibril width 
and carboxylic acid groups were quantified to be ~3.5 nm and ~0.9 mmol/g cellulose, 
respectively.42,52  Here, we have used the low molecular weight antimicrobial OligoG 
in two formulations of CNF dressing materials, both as a surface-coating for films, and 
as a bionanocomposite by incorporation in the aerogels and shown retention of 
antimicrobial activity for both.  Moreover, we demonstrated that these changes were 
associated with significantly decreased levels of pyocyanin production (an important 
virulence factor of P. aeruginosa) when OligoG was incorporated into the aerogel.  We 
have previously shown that the CNF itself does not affect virulence factor production 
by P. aeruginosa,11 so the effects seen in this study were the direct result of the 
antimicrobials used in the CNF formulations.  In these experiments, film F0.2G 
appeared to have significantly greater antimicrobial efficacy than the aerogel 
formulation (A0.2G) in the mixed species biofilm model.  Comparison of the effective 
release of OligoG from the films and aerogels has yet to be determined, but this may 
have played a role in the observed differences in antimicrobial efficacy. 
Three-dimensional (3D) bioprinting allows the accurate deposition of specific 
biomaterials (including CNF) onto virtually any surface and shape.42,43  Indeed, CNF-
(high molecular weight) alginate bioinks are already being developed for cartilage 
regeneration.44  The future use of OligoG as a constituent of a bioink; facilitating more 
 
 
accurate surface deposition and “patterning” in tissue engineering applications such as 
dressing materials is immediately attractive.  For such printing purposes, any bioinks 
used would need to be sufficiently liquid under shear to allow for micro-extrusion, 
regain viscosity after deposition to form 3D structures and have sufficient cross-linking 
abilities to maintain a 3D structure once printed;45 all properties observed in sodium 
alginates.   
In these experiments we also employed (as a control) polyethylene glycol 
(PEG), a widely employed, US Food and Drug Administration (FDA) approved, non-
toxic, polymer that is frequently utilized in pharmaceutical preparations, including 
wound dressings.46  PEG was used as it possesses inherent antibacterial properties and 
may be employed in the context of film formation as a plasticizer to increase 
flexibility.29,47,48  In CNF films, the addition of PEG has been shown to effectively 
increase the maximum force and ‘elongation strain at break’ of CNF films, as well as 
their water absorption capacity.48  Increasing the water absorption of films is potentially 
clinically useful for dressings for exudative wounds.  Whilst the antibacterial effects of 
PEG have been described in the in vitro biofilm model here (which resembles/mimics 
the in vivo wound biofilm environment) incorporating PEG into the CNF materials did 
not result in any significant antimicrobial effects.  Significantly reduced biofilm growth 
was only evident with the surface coated OligoG films.  
Bionanocomposites are increasingly being developed for biomedical uses, such 
as wound dressing applications, in an attempt to utilise the beneficial and/or preferred 
chemical and physical properties of the individual constituents in a single biomaterial.  
Although to date, much of the research on nanocellulose composites appears to have 
focused on the use of bacterially-derived nanocellulose,49-51 it has recently been 
demonstrated that TEMPO CNF gels, films and aerogels have a number of beneficial 
characteristics10,11,19,29 and varying immunogenic properties, which could be valuable 
for specific wound healing applications.52  In the present study, CNF aerogels 
containing OligoG, produced a material with considerably different physical 
characteristics (i.e. increased stratification) from the control materials and when 
compared to the air-dried films.  Most importantly we have shown that OligoG, retains 
its’ anti-bacterial and anti-biofilm properties in TEMPO CNF formulations. 
 
 
 
 
 
CONCLUSIONS   
 
This study showed that CNF-based nanomaterials, in film- or aerogel formulations, can 
be used to design and deliver sustainable dressing materials, with antibacterial and anti-
biofilm properties and which are biodegradable in nature.  The effectiveness of the 
alginate oligosaccharide OligoG as an antimicrobial agent against common wound 
pathogens in the “most difficult to treat” infection model (a bacterial biofilm system) 
was also apparent.  Surface-coating (rather than a bionanocomposite material) proved 
the most effective against both single- and mixed-species bacterial biofilms, with the 
treated dressings exhibiting impaired bacterial growth, disrupted biofilm architecture 
and reduced bacterial virulence factor production in vitro.  In addition to having a lower 
environmental impact than conventional polymer-based dressings, CNF-based 
nanomaterials have been shown here to have considerable potential clinical utility to 
deliver topical antibacterial and anti-biofilm wound healing therapies.   
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